531633 — LINCOLN PHARMACEUTICALS Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹11.66bn
- IN₹9.91bn
- IN₹5.10bn
- 92
- 39
- 81
- 86
R2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 235 | 464 | 922 | 1,153 | 1,138 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,456 | 1,335 | 1,464 | 1,513 | 1,637 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,240 | 2,480 | 3,065 | 3,528 | 3,672 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,134 | 1,132 | 1,119 | 1,476 | 1,569 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 3,660 | 3,894 | 4,594 | 5,344 | 5,874 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 853 | 656 | 735 | 905 | 723 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 966 | 763 | 841 | 1,015 | 849 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2,693 | 3,131 | 3,753 | 4,329 | 5,025 |
Total Liabilities & Shareholders' Equity | 3,660 | 3,894 | 4,594 | 5,344 | 5,874 |
Total Common Shares Outstanding |